DAX+0,47 % EUR/USD0,00 % Gold-0,31 % Öl (Brent)0,00 %

Cor Therapeutics - was ist da los? - 500 Beiträge pro Seite



Beitrag schreiben

Begriffe und/oder Benutzer

 

Hat jemand `ne Ahnung warum es da heute so dunkelrot ausschaut? Habe noch keine Meldung oder ähnliches gefunden?

Schönen Abend allerseits - Gruß, Kathan
COR Therapeutics, Inc. Resets Guidance for Third Quarter and Year-End 2001
SOUTH SAN FRANCISCO, Calif.--(BW HealthWire)--Oct. 3, 2001--COR Therapeutics, Inc. announced today that third quarter sales of INTEGRILIN® (eptifibatide) Injection to wholesalers in the United States will be lower than previously anticipated.

The Company said it expects U.S. sales to wholesalers to be approximately $53 million and worldwide sales to be approximately $59 million for the third quarter of 2001, primarily due to less than anticipated demand in September.

The Company provided new earnings per share guidance for the third quarter of $0.01. For 2001, COR indicated that its new guidance for worldwide sales of INTEGRILIN is $240 to $250 million, and that earnings per share are expected to be $0.11 to $0.13, excluding a possible $10 million milestone payment related to European regulatory approval in angioplasty. The new earnings per share estimates for the quarter and year-end also reflect lower interest income on investments.

COR said that U.S. hospital-based sales for July and August, according to third-party data, were in line with expectations. The Company also noted that in a growing market, patient share for INTEGRILIN increased to over 51 percent in August, the highest ever reported by COR.


Beitrag zu dieser Diskussion schreiben


Es handelt sich hier um eine ältere Diskussion, daher ist das Schreiben in dieser Diskussion nicht mehr möglich. Bitte eröffnen Sie hier eine neue Diskussion.